The goal of our clinical research program at Virginia Mason Franciscan Health is to provide you with a research option at every step of their disease, from initial diagnosis to long-term follow-up of liver disease.
Learn more about our current liver disease trials for chronic liver conditions and liver cancer.
A Phase III Open-Label, Multi-Centre, Randomized Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer.
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEY NOTE-937).
A Phase 2, Multicenter, Clinical Study to Evaluate the Safety and Efficacy of MK-1308A (Coformulated MK-1308/MK-3475) in Combination with Lenvatinib (E7080/MK-7902) in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma.
A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Subjects with Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH).
VM BRITE: A Tissue Registry and Specimen Repository to Support Future Research Projects
Diabetes Related to Acute pancreatitis and its Mechanisms (DREAM)
Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma
A Phase 3, Randomized, Double-Blind Study of Pamrevlumab or Placebo in combination with Gemcitabine Plus Nab-paclitaxel as Neoadjuvant Treatment in Patients with Locally Advanced, Unresectable Pancreatic Cancer
A Phase 1a/b Dose-Escalation Study Followed by Expansion Cohorts of NGM120, a GFRAL Antagonist Monoclonal Antibody Blocking GDF15 Signaling, in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy
Currently enrolling clinical research studies related to endoscopy:
To talk with a clinical research coordinator about non-cancer clinical research trials, call the Center for Digestive Health hotline at 206-341-1295.
To talk with a clinical research coordinator about clinical research trials related to liver, pancreatic or biliary cancer, call the Cancer Clinical Research Unit Research hotline at 206-287-6270.